Records containing: Systemic Lupus Erythematosus
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2019-04-18B Cell Activating Factor Belonging to the TNF (Tumor Necrosis Factor) Family (BAFF) and a Proliferation-inducing Ligand (APRIL) in Patients With Systemic Lupus Erythematosus: Investigating Biomarkers for the Response to the Belimumab Treatment
-
CLINICAL_TRIALS study record update · 2019-03-21A Phase I-II, Randomized, Double-blind, Placebo-controlled, Dose Escalation Study of Neovacs' IFNα-Kinoid in Adult Subjects With Systemic Lupus Erythematosus.
-
CLINICAL_TRIALS study record update · 2019-03-18A Phase 1b Double-Blind, Randomized, Placebo-Controlled Study of the Safety, Pharmacokinetics and Pharmacodynamics of AC0058TA in Patients With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2019-03-13A Phase 2, Multicenter, Open-label, Dose-escalation Study to Evaluate the Safety and Tolerability of Intravenous Dose of MEDI-546, a Human Monoclonal Antibody Directed Against Type I Interferon Receptor (IFNAR), in Japanese Subjects With Active Systemic Lupus Erythematosus (SLE).
-
CLINICAL_TRIALS study record update · 2019-03-05A Phase II, Multi-centre, Randomized, Double Blind, Placebo-controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of ILT-101 in Patients With Active Moderate to Severe Systemic Lupus Erythematosus (SLE)
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2019-01-31Dissemination of the Lupus Interactive Navigator: Measuring Its Uptake and Impact on Global Health and Self-care
-
CLINICAL_TRIALS study record update · 2019-01-18Glucocorticoids Withdrawal in Early Systemic Lupus Erythematosus: a Randomized Placebo-controlled Equivalence Trial
-
CLINICAL_TRIALS study record update · 2019-01-14Hydroxychloroquine Exposure in Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2018-11-21A Randomized, Double-Blind, Placebo-Controlled, Parallel- Group, Phase 2 Study of Baricitinib in Patients With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2018-11-19A Phase II, Multicenter, Open-Label, Dose-Escalation Study to Evaluate Safety and Tolerability of IV or SC Dose of MEDI-545, a Fully Human Monoclonal Antibody Directed Against Interferon Alpha Subtypes, in Japanese Patients Who Have Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2018-11-09A Single Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of GSK1550188 in Chinese Subjects With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2018-11-05Phase I, Safety and Immunogenicity of Gardasil® in Systemic Lupus Erythematosus.
-
CLINICAL_TRIALS study record update · 2018-10-17Prospective Evaluation of Adherence to Antimalarials in Patients With Systemic Lupus and Role of Therapeutic Education
-
CLINICAL_TRIALS study record update · 2018-10-16Walk With Ease Program For Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2018-10-03A Phase 3, Multicenter, Open-label, Extension Study to Assess the Safety and Tolerability of Epratuzumab Treatment in Systemic Lupus Erythematosus Subjects
-
CLINICAL_TRIALS study record update · 2018-09-25Tissue Sodium in Autoimmune Disease
-
CLINICAL_TRIALS study record update · 2018-08-15A Multi-center, Randomized, Placebo-Controlled Trial to Evaluate the Safety, Efficacy, and Pharmacokinetics of Belimumab, a Human Monoclonal Anti-BLyS Antibody, Plus Standard Therapy in Pediatric Patients With Systemic Lupus Erythematosus
-
CLINICAL_TRIALS study record update · 2018-08-09Safety of Tofacitinib, an Oral Janus Kinase Inhibitor, in Systemic Lupus Erythematosus; a Phase Ib Clinical Trial and Associated Mechanistic Studies
-
CLINICAL_TRIALS study record update · 2018-07-12Autophagy Genes and Interleukin-10 in Systemic Lupus Erythematosus Patients
-
CLINICAL_TRIALS study record update · 2018-06-29A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Efficacy and Safety of Four 12-week Treatment Cycles (48 Weeks Total) of Epratuzumab in Systemic Lupus Erythematosus Subjects With Moderate to Severe Disease
-
CLINICAL_TRIALS study record update · 2018-06-29A Phase 3, Randomized, Double-blind, Placebo-controlled, Multicenter Study of the Efficacy and Safety of Four 12-week Treatment Cycles (48 Weeks Total) of Epratuzumab in Systemic Lupus Erythematosus Subjects With Moderate to Severe Disease
-
CLINICAL_TRIALS study record update · 2018-06-28Lupus Interval Monitoring to Manage Disease Flare and Enable Treatment Optimization
-
CLINICAL_TRIALS study record update · 2018-06-19A Phase 3, Multicenter, Randomized, Double-blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of Subcutaneous LY2127399 in Patients With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2018-06-18Phase 1 Study of Vitamin D Therapy in Patients With Systemic Lupus Erythematosus (SLE)
-
CLINICAL_TRIALS study record update · 2018-06-15Intervention to Improve Quality of Life for African-AmericaN Lupus Patients (IQAN)